Incorporated on 1 January 1978 with headquarters in London, United Kingdom. Hikma Pharmaceuticals is a shareholding company operating within the Healthcare sector. The company specialize in manufacturing broad range of branded and non-branded generic medicine. The company operates several manufacturing plants across the United States of America, Europe and MENA regions. Hikma Pharmaceuticals is a public company cross-listed on Nasdaq Dubai since 26 April 2006. and on the London Stock Exchange since 4 November 2005.